KBC Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260M | Buy |
|
|||||
|
2025
Q1 | $207M | Sell |
|
|||||
|
2024
Q4 | $190M | Sell |
|
|||||
|
2024
Q3 | $191M | Sell |
|
|||||
|
2024
Q2 | $249M | Buy |
|
|||||
|
2024
Q1 | $231M | Buy |
|
|||||
|
2023
Q4 | $115M | Buy |
|
|||||
|
2023
Q3 | $92.7M | Sell |
|
|||||
|
2023
Q2 | $112M | Buy |
|
|||||
|
2023
Q1 | $77.3M | Buy |
|
|||||
|
2022
Q4 | $73.2M | Buy |
|
|||||
|
2022
Q3 | $49.1M | Buy |
|
|||||
|
2022
Q2 | $47.5M | Buy |
|
|||||
|
2022
Q1 | $41M | Sell |
|
|||||
|
2021
Q4 | $65.7M | Buy |
|
|||||
|
2021
Q3 | $57.9M | Sell |
|
|||||
|
2021
Q2 | $86.5M | Buy |
|
|||||
|
2021
Q1 | $66.4M | Buy |
|
|||||
|
2020
Q4 | $294M | Sell |
|
|||||
|
2020
Q3 | $70.6M | Buy |
|
|||||
|
2020
Q2 | $81.6M | Buy |
|
|||||
|
2020
Q1 | $45.4M | Sell |
|
|||||
|
2019
Q4 | $44.7M | Sell |
|
|||||
|
2019
Q3 | $51.9M | Buy |
|
|||||
|
2019
Q2 | $28.3M | Buy |
|
|||||
|
2019
Q1 | $23.6M | Sell |
|
|||||
|
2018
Q4 | $23.9M | Sell |
|
|||||
|
2018
Q3 | $33.6M | Buy |
|
|||||
|
2018
Q2 | $15.1M | Sell |
|
|||||
|
2018
Q1 | $17.4M | Sell |
|
|||||
|
2017
Q4 | $18.5M | Sell |
|
|||||
|
2017
Q3 | $60.3M | Buy |
|
|||||
|
2017
Q2 | $46.7M | Sell |
|
|||||
|
2017
Q1 | $87.8M | Buy |
|
|||||
|
2016
Q4 | $80.9M | Buy |
|
|||||
|
2016
Q3 | $79.2M | Buy |
|
|||||
|
2016
Q2 | $58.1M | Buy |
|
|||||
|
2016
Q1 | $44.1M | Sell |
|
|||||
|
2015
Q4 | $51.9M | Buy |
|
|||||
|
2015
Q3 | $48.3M | Sell |
|
|||||
|
2015
Q2 | $58.9M | Buy |
|
|||||
|
2015
Q1 | $28.6M | Sell |
|
|||||
|
2014
Q4 | $54M | Buy |
|
|||||
|
2014
Q3 | $21.7M | Sell |
|
|||||
|
2014
Q2 | $82.8M | Sell |
|
|||||
|
2014
Q1 | $75.8M | Sell |
|
|||||
|
2013
Q4 | $83.9M | Buy |
|
|||||
|
2013
Q3 | $67.3M | Buy |
|
|||||
|
2013
Q2 | $43M | Buy |
|